Katedra za farmaciju

View Statistics Email Alert RSS Feed
Organization name
Katedra za farmaciju
Parent OrgUnit
City
Novi Sad
Country
Serbia

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Refined By:
Author:  Abenavoli L.

Results 1-20 of 26 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
11-Jan-2015Adiponectin serum level in chronic hepatitis C infection and therapeutic profilePeta V.; Torti C.; Milić, Nataša ; Focà A.; Abenavoli L.
21-Jan-2014Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean dietAbenavoli L.; Milić N. ; Peta V.; Alfieri F.; De Lorenzo A.; Bellentani S.
31-Dec-2012Anti-oxidant therapy in non-alcoholic fatty liver disease: The role of silymarinAbenavoli L.; Milić, Nataša ; Capasso F.
41-Nov-2013Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pyloriAbenavoli L.; Milić, Nataša ; Masarone M.; Persico M.
51-Feb-2013Dietary Intervention in Non-Alcoholic Fatty Liver DiseaseAbenavoli L.; Milić, Nataša 
612-Aug-2017Effect of mediterranean diet and antioxidant formulation in non-alcoholic fatty liver disease: A randomized studyAbenavoli L.; Greco M.; Milić, Nataša ; Accattato F.; Foti D.; Gulletta E.; Luzza F.
71-Apr-2015Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver diseaseAbenavoli L.; Greco M.; Nazionale I.; Peta V.; Milić, Nataša ; Accattato F.; Foti D.; Gulletta E.; Luzza F.
82-Sep-2017Gut microbiota changes and chronic hepatitis C virus infectionPreveden, Andrej; Scarpellini E.; Milić, Nataša ; Luzza F.; Abenavoli L.
91-Jan-2012Haemophagocytic syndrome associated with mucormycosis infectionArena V.; De-Giorgio F.; Pennacchia I.; Manna R.; Vetrugno G.; Stigliano E.; Milić, Nataša ; Gasbarrini G.; Abenavoli L.
101-Jan-2014Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3Abenavoli L.; Masarone M.; Peta V.; Milić, Nataša ; Kobyliak N.; Rouabhia S.; Persico M.
111-Jan-2015Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: A case seriesAbenavoli L.; Peta V.; Milić, Nataša 
121-Mar-2013Liver steatosis in celiac disease: The open doorAbenavoli L.; Luigiano C.; Larussa T.; Milić, Nataša ; De Lorenzo A.; Stelitano L.; Morace C.; Consolo P.; Miraglia S.; Fagoonee S.; Virgilio C.; Luzza F.; Pellicano R.
131-Jan-2014Low 25-hydroxyvitamin D3 serum levels and non-alcoholic fatty liver diseaseAbenavoli L.; Milić, Nataša ; Luigiano C.
141-Jan-2014Metformin in the treatment of non-alcoholic fatty liver disease: Safety, efficacy and mechanismRouabhia S.; Milić, Nataša ; Abenavoli L.
151-Nov-2018Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseasesAbenavoli L.; Izzo A.; Milić, Nataša ; Cicala C.; Santini A.; Capasso R.
161-Mar-2011Milk thistle for treatment of nonalcoholic fatty liver diseaseAbenavoli L.; Aviello G.; Capasso R.; Milić, Nataša ; Capasso F.
171-Oct-2010Milk thistle in liver diseases: Past, present, futureAbenavoli L.; Capasso R.; Milić, Nataša ; Capasso F.
181-Jan-2015Non-alcoholic fatty liver disease severity, central fat mass and adinopectin: A close relationshipAbenavoli L.; Di Renzo L.; Guzzi P.; Pellicano R.; Milić, Nataša ; De Lorenzo A.
191-Jan-2019Olive oil antioxidants and non-alcoholic fatty liver diseaseAbenavoli L.; Milanović, Maja ; Milić, Nataša ; Luzza F.; Giuffrè A.
201-Feb-2013A pathogenetic link between non-alcoholic fatty liver disease and celiac diseaseAbenavoli L.; Milić, Nataša ; De Lorenzo A.; Luzza F.